[Audio] EP05 Clinical Demonstration 17 – Treating Suicide Patients – Donald Meichenbaum, Ph.D.

You are currently accessing the institutional-grade blueprint for <b>[Audio] EP05 Clinical Demonstration 17 – Treating Suicide Patients – Donald Meichenbaum, Ph.D.</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.

[Instant Download]

– Immediately deliver the download link after receiving the payment

Purchase [Audio] EP05 Clinical Demonstration 17 – Treating Suicide Patients – Donald Meichenbaum, Ph.D. courses at here with PRICE $15 $5

---

Topic Areas:

Clinical Demonstration

Category:

Evolution of Psychotherapy | Evolution of Psychotherapy 2005

Faculty:

Donald Meichenbaum, PhD

Duration:

57 Minutes

Format:

Audio Only

Original Program Date :

Dec 10, 2005

Description

Description:

Educational Objectives:

1. To describe the role that cognitions and related factors play in suicide.
2. To list five core tasks in treating suicidal patients. 

*Sessions may be edited for content and to preserve confidentiality*

Faculty

Donald Meichenbaum, PhD Related seminars and products: 81

---

Donald Meichenbaum, Ph.D in Clinical Psychology is currently Research Director of Melissa Institute for Violence Prevention, Miami (melissainstitute.org). He is one of the founders of cognitive behavior therapy. He was voted one of the most influential psychotherapists of the 20th century. Latest books include “Roadmap to Resilience” (www.roadmaptoresilience.com) and “Evolution of Cognitive Behavior Therapy: A Personal and Professional Journey.”

---

Salepage: https://catalog.erickson-foundation.org/item/ep05-clinical-demonstration-17-treating-suicide-patients-donald-meichenbaum-phd-24219

Archive: https://archive.ph/Yu0aA

Purchase [Audio] EP05 Clinical Demonstration 17 – Treating Suicide Patients – Donald Meichenbaum, Ph.D. courses at here with PRICE $15 $5

Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>